D E Macfarlane. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anti-Bacterial Agents/therapeutic useBacterial Infections/drug therapyBacterial Infections/etiologyBacterial Infections/prevention & controlBacteriuria/drug therapyBacteriuria/etiologyBacteriuria/prevention & controlCatheters, Indwelling/adverse effectsCross Infection/drug therapyCross Infection/etiologyCross Infection/prevention & controlHumansMethenamine/therapeutic useNalidixic Acid/therapeutic useNitrofurantoin/therapeutic useUrinary Catheterization/adverse effectsUrinary Catheterization/methodsUrinary Tract Infections/drug therapyUrinary Tract Infections/etiologyUrinary Tract Infections/prevention & control
Substances： See more » Anti-Bacterial AgentsNalidixic AcidNitrofurantoinMethenamine
Year: 1985 PMID： 3891871 DOI： 10.1016/s0163-4453(85)91480-x
Source DB: PubMed Journal: J Infect ISSN： 0163-4453 Impact factor: 6.072